Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Severe Traumatic Brain Injury
NCT06870370Phase 3Not yet recruiting
- Sponsor
- Tanta University
- Start
- Sep 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in traumatic brain injury (TBI) comparing Propranolol group with Placebo group (2 arms). Primary endpoint: Mortality at 7 days. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06870370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06870370.